IRIS
DI IOIA, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.619
EU - Europa 1.372
AS - Asia 753
SA - Sud America 55
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
AF - Africa 2
Totale 3.813
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.609
CN - Cina 315
IE - Irlanda 225
IT - Italia 210
SG - Singapore 203
DE - Germania 202
UA - Ucraina 180
TR - Turchia 154
GB - Regno Unito 148
SE - Svezia 138
FI - Finlandia 96
FR - Francia 90
BR - Brasile 49
IN - India 49
RU - Federazione Russa 31
CZ - Repubblica Ceca 17
BE - Belgio 12
CA - Canada 8
EU - Europa 7
CH - Svizzera 6
HK - Hong Kong 6
VN - Vietnam 6
AU - Australia 5
IR - Iran 4
PK - Pakistan 4
AT - Austria 2
DK - Danimarca 2
GR - Grecia 2
KR - Corea 2
MX - Messico 2
PL - Polonia 2
PY - Paraguay 2
RS - Serbia 2
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
BD - Bangladesh 1
CL - Cile 1
EG - Egitto 1
ES - Italia 1
HR - Croazia 1
ID - Indonesia 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
NL - Olanda 1
PH - Filippine 1
RO - Romania 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 3.813
Salva come PNG Salva come JPEG
Città #
Chandler 288
Jacksonville 251
Dublin 222
Singapore 133
Southend 116
Munich 110
Princeton 94
The Dalles 88
Nanjing 85
Ashburn 84
Ann Arbor 76
Izmir 73
Chieti 71
Beijing 69
Dearborn 62
Helsinki 52
Wilmington 40
Cambridge 39
New York 35
Altamura 32
Santa Clara 31
Nanchang 29
Boardman 21
Washington 18
Woodbridge 18
Los Angeles 17
Grevenbroich 15
Brno 14
Kunming 14
Shenyang 13
Brussels 12
Guangzhou 12
Jiaxing 12
Hebei 11
Norwalk 11
Tianjin 11
Hangzhou 9
San Mateo 8
Changsha 7
Frankfurt am Main 7
Houston 7
Monmouth Junction 7
Nuremberg 7
Dong Ket 6
Falls Church 6
Fribourg 6
Hong Kong 6
Jinan 6
Lanzhou 6
London 6
Camerino 5
Pescara 5
Roseto Degli Abruzzi 5
Changchun 4
Curitiba 4
Edinburgh 4
Hanover 4
Montesilvano Marina 4
San Vito Chietino 4
Seattle 4
Teramo 4
Toronto 4
Zhengzhou 4
Ankara 3
Ardabil 3
Augusta 3
La Spezia 3
Milan 3
Mumbai 3
Ningbo 3
Olomouc 3
Rome 3
Taizhou 3
Tatura 3
Torino 3
Belgrade 2
Benevento 2
Boston 2
Campodipietra 2
Copenhagen 2
Council Bluffs 2
Düsseldorf 2
Fairfield 2
Istanbul 2
Jyväskylä 2
Karachi 2
Kraków 2
L'aquila 2
Leawood 2
Padova 2
Palermo 2
Paulínia 2
Pelotas 2
Pianella 2
Rawalpindi 2
Redmond 2
Redwood City 2
San Francisco 2
San Jose 2
Sumaré 2
Totale 2.514
Salva come PNG Salva come JPEG
Nome #
Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of Multiple Sclerosis patients 290
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis 154
Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid 135
Integration of metabolomics and proteomics in multiple sclerosis: from biomarkers discovery to personalized medicine 117
Cleavage of cystatin C is not associated with multiple sclerosis 115
Metabolomic Signature in Sera of Multiple Sclerosis Patients during Pregnancy 108
A lipidomic investigation for the caracterisation of CSF lipid profile in patients with multiple sclerosis 108
UNRAVELING THE MOLECULAR REPERTOIRE OF TEARS AS A SOURCE OF BIOMARKERS: BEYOND OCULAR DISEASES 105
The Multiple Sclerosis Knowledge Questionnaire: a self administered instrument for recently diagnosed patients 102
Increasing age at disability milestones among MS patients in the MSBase Registry 97
Acetylcholine in multiple sclerosis: possible involvement in the modulation of the immune response and in oligodendrocyte recruitment. 96
Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: A report from a single Italian center 96
Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis 96
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 95
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. 92
Data of safety in a single-center alemtuzumab treated population 90
TLC-MALDI-Imaging approach for lipidomics studies in cerebrospinal fluid reveals low levels of sphingomyelin in multiple sclerosis patients 88
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis 84
Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients 84
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 82
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. 81
Nail loss after teriflunomide treatment: a new potential adverse event 78
OXIDATIVE MODIFICATIONS OF CEREBRAL TRANSTHYRETIN ARE ASSOCIATED WITH MULTIPLE SCLEROSIS 76
JCV-Ab serostatus in MS patients treated with Natalizumab 76
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 76
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy. 75
An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. 75
Natalizumab-associated PML-IRIS: the Chieti experience. 74
Neuropsychological testing and quantitative electroencephalography: a search of neurophysiological markers of cognitive decline in multiple sclerosis 73
Mass spectrometry based metabonomics of the cerebrospinalfluid highlights a correlation between polar lipids and carnitines levels in multiple sclerosis patients. 72
Patient adherence to and tolerability of self-administered interferon beta-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study 71
Prevalence of JC virus antibodies in human serum and seroconversion rate with first-generation and second generation ELISA: the novel assay improves specificity andsensitivity to detect anti-JC virus antibodies 71
Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group 70
A difficult pediatric case: ADEM evolving in multiple sclerosis complicated by progressive multifocal leukoencephalopathy after Natalizumab treatment. 69
Multiphasic Adem or Multiple Sclerosis? Treatement implications. 69
Progressive multifocal leukoencephalopathy associated with natalizumab in paediatric multiple sclerosis 68
Proteomic investigations on differential post-translational modification of transthyretin in multiple sclerosis. 68
Contribution of metabolomics to multiple sclerosis diagnosis, prognosis and treatment 68
Treatment discontinuation issues in fingolimod treated patients: the Chieti experience. 66
Neuropsychological testing and event-related potentials: markers of cognitive impairment in patients with multiple sclerosis 61
Simultaneous early-onset severe autoimmune hemolytic anemia and albuminuria during alemtuzumab treatment for multiple sclerosis 55
Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis 53
Relation between Pro-inflammatory Cytokines and Acetylcholine Levels in Relapsing-Remitting Multiple Sclerosis Patients 50
Spinal cord injury in a patient with multiple sclerosis (MS) with secondary hydromyelia 50
Lipidomics analysis reveals low levels of phosphatidylcholines and sphingomyelins in cerebrospinal fluido f multiple sclerosis patients. 49
Totale 3.928
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.670
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.670
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202083 0 0 0 0 0 0 0 0 0 0 68 15
2020/2021283 46 3 59 3 5 52 5 0 41 25 30 14
2021/2022232 4 4 9 42 9 13 10 20 16 9 24 72
2022/2023757 61 109 43 74 93 133 34 54 104 15 24 13
2023/2024394 17 18 33 6 30 181 48 5 1 8 2 45
2024/2025763 50 103 110 11 23 63 94 52 103 44 110 0
Totale 3.928